|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01069 CN HEALTH TECH
Nominal 
0.049 +0.002 (+4.255%) | 2024/12 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/06 RMB(K¥) | |
| Turnover | 31,112 | 63.575% | 19,020 | 23,021 | 3,777 | 3,859 |
| Cost of Sales | (28,335) | 85.657% | (15,262) | (17,952) | (3,864) | 0 |
| Gross Profit | 2,777 | -26.104% | 3,758 | 5,069 | (87) | 3,859 |
| 2024/12 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/06 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | 202,024 | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | 5,042 | -97.497% | 201,423 | (1,244) | (5,456) | (21,946) | |
| Taxation | (64) | 3100.000% | (2) | 0 | (2) | (95) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 0 | 0 | 0 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 4,978 | -97.529% | 201,421 | (1,244) | (5,458) | (22,041) | |
| 2024/12 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/06 RMB(K¥) | |
| Net Finance Costs / (Income) | 1,335 | 2681.250% | 48 | 8,964 | 6,712 | 11,691 |
| Depreciation & Amortisation | 2,830 | 53.721% | 1,841 | 732 | 966 | 2,482 |
| Directors' Emoluments | 421 | -60.801% | 1,074 | 1,139 | 2,417 | 1,817 |
| 2024/12 - Interim | %Chg (Compare to Interim) | 2023/12 | 2022/12 | 2021/12 | 2020/06 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2024/12 - Interim | %Chg (Compare to Interim) | 2023/12 | 2022/12 | 2021/12 | 2020/06 | |
| EPS (cts) | 0.630 | -98.038% | 32.110 | -1.130 | -5.000 | -20.000 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 0.029 | -- | 0.023 | (2.914) | (2.505501) | 2.040861 |
| Remarks: | Real time quote last updated: 30/04/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB 4,978,000 |
| %Change | -97.529% |
| EPS / (LPS) | RMB 0.006 |
| NBV Per Share (¥) | RMB 0.029 |